99 related articles for article (PubMed ID: 3557725)
1. Evolution of renal function under chronic oral administration of labetalol.
Labeeuw M; Zech P; Pozet N; Hadj-Aissa A; Traeger J
Int J Clin Pharmacol Ther Toxicol; 1987 Jan; 25(1):23-5. PubMed ID: 3557725
[TBL] [Abstract][Full Text] [Related]
2. The short term effects of oral labetalol in patients with chronic renal disease and hypertension.
Innes A; Gemmell HG; Smith FW; Edward N; Catto GR
J Hum Hypertens; 1992 Jun; 6(3):211-4. PubMed ID: 1629891
[TBL] [Abstract][Full Text] [Related]
3. Acute effects of the oral administration of midodrine, an alpha-adrenergic agonist, on renal hemodynamics and renal function in cirrhotic patients with ascites.
Angeli P; Volpin R; Piovan D; Bortoluzzi A; Craighero R; Bottaro S; Finucci GF; Casiglia E; Sticca A; De Toni R; Pavan L; Gatta A
Hepatology; 1998 Oct; 28(4):937-43. PubMed ID: 9755229
[TBL] [Abstract][Full Text] [Related]
4. Effect of propranolol and labetalol on renal haemodynamics at rest and during exercise in essential hypertension.
Pedersen EB; Larsen JS
Postgrad Med J; 1980; 56 Suppl 2():27-32. PubMed ID: 7433339
[TBL] [Abstract][Full Text] [Related]
5. [Determinant factors in the acute functional deterioration caused by the inhibition of the conversion enzyme in reno-vascular arterial hypertension].
Ribstein J; Mourad G; Mimran A
Arch Mal Coeur Vaiss; 1987 Jun; 80(6):866-9. PubMed ID: 3116987
[TBL] [Abstract][Full Text] [Related]
6. Blood pressure, plasma volume, extracellular volume and glomerular filtration rate during treatment with labetalol in essential hypertension.
Rasmussen S; Nielsen PE
Postgrad Med J; 1980; 56 Suppl 2():33-6. PubMed ID: 7433340
[TBL] [Abstract][Full Text] [Related]
7. [Effects of labetalol, a new alpha- and beta-adrenoreceptor blocking drug, on arterial pressure, renal function and renin activity (author's transl)].
Zech P; Pozet N; Sassard J; Vincent M
Nouv Presse Med; 1980 Mar; 9(15):1087-90. PubMed ID: 7008020
[TBL] [Abstract][Full Text] [Related]
8. Effects of CS-905, a novel dihydropyridine calcium channel blocker, on arterial pressure, renal excretory function, and inner medullary blood flow in the rat.
Yagil Y; Miyamoto M; Frasier L; Oizumi K; Koike H
Am J Hypertens; 1994 Jul; 7(7 Pt 1):637-46. PubMed ID: 7946166
[TBL] [Abstract][Full Text] [Related]
9. [Effect of cyclosporin A on blood pressure and renal hemodynamics in insulin dependent diabetes].
Hannedouche T; Delgado A; Gnionsahe A; Boitard C; Lacour B; Grünfeld JP
Arch Mal Coeur Vaiss; 1988 Jun; 81 Spec No():221-3. PubMed ID: 3142410
[TBL] [Abstract][Full Text] [Related]
10. Does L-arginine alter proteinuria and renal hemodynamics in patients with chronic glomerulonephritis and hypertension?
Wolf SC; Erley CM; Kenner S; Berger ED; Risler T
Clin Nephrol; 1995 Jan; 43 Suppl 1():S42-6. PubMed ID: 7781205
[TBL] [Abstract][Full Text] [Related]
11. A randomized and double-blind comparison of isradipine and spirapril as monotherapy and in combination on the decline in renal function in patients with chronic renal failure and hypertension.
Petersen LJ; Petersen JR; Talleruphuus U; Møller ML; Ladefoged SD; Mehlsen J; Jensen HA
Clin Nephrol; 2001 May; 55(5):375-83. PubMed ID: 11393383
[TBL] [Abstract][Full Text] [Related]
12. Effects of diltiazem hydrochloride on the reduction of blood pressure, and cardiac and renal functions in essential hypertensive patients with renal dysfunction.
Ohashi H; Ishiguro M; Yasue T; Kotoo Y; Kamakura M; Watanabe S; Sugishita N; Morita N
Int J Clin Pharmacol Ther Toxicol; 1987 Jun; 25(6):291-6. PubMed ID: 3623733
[TBL] [Abstract][Full Text] [Related]
13. Beta blockers and renal function: a reappraisal.
Epstein M; Oster JR
J Clin Hypertens; 1985 Mar; 1(1):85-99. PubMed ID: 2873206
[TBL] [Abstract][Full Text] [Related]
14. Effects of intensified blood-pressure reduction on renal function and albumin excretion in primary hypertension. Addition of felodipine or ramipril to long-term treatment with beta-blockade.
Siewert-Delle A; Ljungman S; Hartford M; Wikstrand J
Am J Hypertens; 1995 Feb; 8(2):113-23. PubMed ID: 7755939
[TBL] [Abstract][Full Text] [Related]
15. Effect of light exercise on renal hemodynamics in patients with hypertension and chronic renal disease.
Svarstad E; Myking O; Ofstad J; Iversen BM
Scand J Urol Nephrol; 2002; 36(6):464-72. PubMed ID: 12623513
[TBL] [Abstract][Full Text] [Related]
16. High renal plasma flow lability in the kidneys of hypertensive patients.
Iaina A; Feldman RD; Silverberg DS; Eliahou HE
Biomedicine; 1978 Jun; 29(4):126-9. PubMed ID: 687755
[TBL] [Abstract][Full Text] [Related]
17. Enhanced sodium retention after acute nitric oxide blockade in mildly sodium loaded patients with essential hypertension.
Bech JN; Nielsen EH; Pedersen RS; Svendsen KB; Pedersen EB
Am J Hypertens; 2007 Mar; 20(3):287-95. PubMed ID: 17324742
[TBL] [Abstract][Full Text] [Related]
18. Improvement in renal function by felodipine during cyclosporine treatment in acute and short-term studies.
Pedersen EB; Madsen JK; Sørensen SS; Zachariae H
Kidney Int Suppl; 1996 Jun; 55():S94-6. PubMed ID: 8743522
[TBL] [Abstract][Full Text] [Related]
19. Regulation of glomerular filtration in essential hypertension: role of abnormal Na+ transport and atrial natriuretic peptide.
Semplicini A; Ceolotto G; Sartori M; Maresca A; Baritono E; De Toni R; Paparella I; Calò L
J Nephrol; 2002; 15(5):489-96. PubMed ID: 12455714
[TBL] [Abstract][Full Text] [Related]
20. Measurement of changes in glomerular filtration rate induced by atrial natriuretic peptide in the rat kidney.
Caron N; Kramp R
Exp Physiol; 1999 Jul; 84(4):689-96. PubMed ID: 10481226
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
